AJP - GI Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (August 11, 2005). doi:10.1152/ajpgi.00230.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/6/G1061    most recent
00230.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berg, A.
Right arrow Articles by Sjostrand, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berg, A.
Right arrow Articles by Sjostrand, S. E.
Submitted on May 19, 2005
Accepted on August 5, 2005

Nitric oxide inhibits gastric acid secretion by increasing intra parietal cell levels of cGMP in isolated human gastric glands

Anna Berg1, Stefan Redeen2, Magnus Grenegard3, Ann-Charlott Ericson1*, and Sven Erik Sjostrand3

1 Department of Biomedicine and Surgery, Division of Cell Biology, Linkoping University, Linkoping, Sweden
2 Surgery Department, University Hospital, Linkoping, Sweden
3 Department of Medicine and Care, Division of Pharmacology, Linkoping University, Linkoping, Sweden

* To whom correspondence should be addressed. E-mail: loter{at}ibk.liu.se.

We have previously identified cells containing the enzyme nitric oxide synthase (NOS) in the human gastric mucosa. Moreover, we have demonstrated that endogenous and exogenous nitric oxide (NO) was shown to decrease histamine-stimulated acid secretion in isolated human gastric glands. The present investigation aimed to further determine whether this action of NO was mediated by the activation of guanylyl cyclase (GC) and subsequent production of cyclic GMP (cGMP). Isolated gastric glands were obtained after enzymatic digestion of biopsies taken from the oxyntic mucosa of healthy volunteers. Acid secretion was assessed by measuring 14Caminopyrine accumulation and the concentration of cGMP was determined by radioimmunoassay (RIA). In addition, immunohistochemistry was used to examine the localization of cGMP in mucosal preparations after stimulation with the NO-donor S-nitroso-N-acetylpenicillamine (SNAP). SNAP (0.1 mM) was shown to decrease acid secretion stimulated by histamine (50 µM); this effect was accompanied by an increase in cGMP production, which was histologically localized to the parietal cells. The membrane permeable cGMP analogue dibuturyl-cGMP (db-cGMP; 0.1-1 mM), dose-dependently inhibited acid secretion. Additionally, the effect of SNAP was prevented by pre-incubating the glands with the GC inhibitor 4H-8-Bromo-1,2,4- oxadiazolo[3,4-d]benz[b][1,4]oxazin-1-one (NS 2028) (10 µM). We therefore suggest that NO in the human gastric mucosa is of physiological importance in regulating acid secretion. Furthermore, the results show that NO-induced inhibition of gastric acid secretion is a cGMP-dependent mechanism in the parietal cell involving the activation of GC.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.